Publications

Multiple academic articles reporting on the results of VAC4EU studies have been published in Vaccine, Drug Safety, and other journals. All VAC4EU publications are open access, with links to full text PDFs available below.

    Publications

Luxi N, et al. Safety of COVID-19 Vaccines among People with History of Allergy: A European Active Surveillance Study. Vaccines. 17 Sept 2024.
Bots SH, et al. Applying two approaches to detect unmeasured confounding due to time-varying variables in a self-controlled risk interval design evaluating COVID-19 vaccine safety signals, using myocarditis as a case example. American Journal of Epidemiology. 3 July 2024.
Bellitto C, et al. What is the safety of COVID-19 vaccines in immunocompromised patients? Results from the European “Covid Vaccine Monitor” active surveillance study. Drug Safety. 22 June 2024.
Schultze A, et al. A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases. Vaccine. 5 Apr 2024.
Raethke M, et al. Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study. Vaccine. 6 Mar 2024 (online).
Ciccimarra F, et al. Safety Monitoring of COVID-19 Vaccines in Persons with Prior SARS-CoV-2 Infection: A European Multi-Country Study. Vaccines. 26 Feb 2024.
Riefolo, F., et al. Effectiveness of homologous/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three European countries. Elsevier. 13 Nov 2023.
Ahmadizar F, et al. Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials. Drug Safety. 1 June 2023.
Raethke M, et al. Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First Dose. Drug Safety. 7 Apr 2023.
Willame C, et al. Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases – an ACCESS cohort study. Vaccine. 1 Apr 2023.
Bots SH, et al. Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries. Frontier Pharmacology. 24 Nov 2022.
Emborg HD, et al. ADVANCE system testing: can coverage of pertussis vaccination be estimated in European countries using electronic healthcare databases: an example. Vaccine. 22 Dec 2022.
Weibel D, et al. ADVANCE system testing: Can safety studies be conducted using electronic healthcare data? An example using pertussis vaccination. Vaccine. 22 Dec 2020.
Bollaerts K, et al. ADVANCE system testing: Benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and individual-level state transition modelling.. Vaccine. 22 Dec 2020.